Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Halozyme Therapeutics (HALO)
NASDAQ:HALO
Halozyme (HALO) Stock Price & Analysis
720 Followers
HALO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$29.85 - $59.40
Previous Close$39.95
Volume732.93K
Average Volume (3M)895.85K
Market Cap
$5.30B
Enterprise Value$6.32B
Total Cash (Recent Filing)$483.28M
Total Debt (Recent Filing)$1.50B
Price to Earnings (P/E)21.3
Beta0.91
Next Earnings
Feb 20, 2024EPS Estimate
$0.77Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.87
Shares Outstanding132,098,110
10 Day Avg. Volume859,760
30 Day Avg. Volume895,850
Standard Deviation0.13
R-Squared0.30
Alpha0.00928
Financial Highlights & Ratios
Price to Book (P/B)-8.06
Price to Sales (P/S)8.00
Price to Cash Flow (P/CF)10.00
P/FCF Ratio10.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.09
Enterprise Value/Gross Profit12.13
Enterprise Value/Ebitda15.54
Forecast
1Y Price Target
$51.50Price Target Upside28.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Halozyme News
Pre-EarningsHALO Upcoming Earnings Report: What to Expect?
Ownership Overview
12.28% Insiders
32.90% Mutual Funds
50.53% Other Institutional Investors
4.29% Public Companies and
Individual Investors
HALO FAQ
What was Halozyme Therapeutics’s price range in the past 12 months?
Halozyme Therapeutics lowest stock price was $29.85 and its highest was $59.40 in the past 12 months.
What is Halozyme Therapeutics’s market cap?
Currently, no data Available
When is Halozyme Therapeutics’s upcoming earnings report date?
Halozyme Therapeutics’s upcoming earnings report date is Feb 20, 2024 which is in 72 days.
How were Halozyme Therapeutics’s earnings last quarter?
Halozyme Therapeutics released its earnings results on Nov 06, 2023. The company reported $0.75 earnings per share for the quarter, beating the consensus estimate of $0.706 by $0.044.
Is Halozyme Therapeutics overvalued?
According to Wall Street analysts Halozyme Therapeutics’s price is currently Undervalued.
Does Halozyme Therapeutics pay dividends?
Halozyme Therapeutics does not currently pay dividends.
What is Halozyme Therapeutics’s EPS estimate?
Halozyme Therapeutics’s EPS estimate is $0.77.
How many shares outstanding does Halozyme Therapeutics have?
Halozyme Therapeutics has 132,098,110 shares outstanding.
What happened to Halozyme Therapeutics’s price movement after its last earnings report?
Halozyme Therapeutics reported an EPS of $0.75 in its last earnings report, beating expectations of $0.706. Following the earnings report the stock price went up 10.04%.
Which hedge fund is a major shareholder of Halozyme Therapeutics?
Among the largest hedge funds holding Halozyme Therapeutics’s share is Driehaus Capital Management LLC. It holds Halozyme Therapeutics’s shares valued at 20M.
---
Halozyme Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$51.50 (28.91% Upside)
$51.50 (28.91% Upside)
Blogger Sentiment
Bullish
HALO Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 671.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 3.8%
Last 30 Days ▲ 3.8%
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-30.94%
12-Months-Change
Fundamentals
Return on Equity
146.69%
Trailing 12-Months
Asset Growth
1.51%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Halozyme Therapeutics
Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.
---
Top 5 ETFs holding HALO
Vanguard Total Stock Market ETF
$140.06M
Vanguard Health Care ETF
$15.27M
FCF US Quality ETF
$592.29K
Vanguard Russell 3000 ETF
$284.75K
SPDR S&P 1500 Value Tilt ETF
$15.98K
Up to five ETFs with an Outperform Smart Score that hold HALO. The ETFs are listed according to market value of HALO within the ETF
---